Trends and Disparities in Mortality From Coexisting Chronic Liver Disease and Mental Disorders in the US (1999–2023) with Forecasts to 2030
This study analyzes US mortality data from 1999 to 2023 to reveal a marked acceleration in deaths from coexisting chronic liver disease and mental disorders, highlighting significant demographic disparities and projecting a continued rise in mortality rates through 2030, thereby underscoring the urgent need for systemic healthcare reforms.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the United States, two distinct health challenges have been rising in tandem, creating a complex web of risk for millions of people. On one side is chronic liver disease, a condition where the liver becomes inflamed and scarred over time, often due to factors like heavy alcohol use, viral infections, or metabolic issues. On the other side are mental health disorders, which encompass a wide range of conditions affecting how people think, feel, and behave, including depression, anxiety, and substance use problems. While doctors have long known that these two conditions often appear together—sometimes because the stress of a serious illness worsens mental health, and other times because substance use damages the liver—there has been a lack of clear, national data showing how this combination affects death rates over time. Understanding the scale of this overlap is crucial because it reveals where the healthcare system is failing its most vulnerable patients and where the gaps in care are widest.
A team of researchers set out to fill this gap by examining death records from across the country spanning twenty-five years, from 1999 to 2023. They focused specifically on adults aged thirty-five and older who died with both chronic liver disease and a mental health disorder listed as contributing causes. By analyzing over 148,000 such deaths, the researchers were able to track how the risk of dying from this combination of conditions changed over time and how it differed among various groups of people. They looked at patterns based on gender, age, race, where people lived, and whether they resided in cities or rural areas. Their goal was not just to count the deaths, but to understand the story behind the numbers: who is most at risk, how the risk has shifted, and what the future might hold if current trends continue.
The study revealed a troubling trajectory. At the start of the period in 1999, the age-adjusted death rate for people with both conditions was 2.67 per 100,000 people. By 2023, that number had climbed to 4.26 per 100,000. The path to this increase was not a straight line; the rate rose sharply in the early 2000s, dropped significantly between 2001 and 2008, and then began a steep and persistent climb that has continued through the present day. This recent surge suggests that the combination of liver and mental health issues has become a more deadly public health crisis in the last decade and a half.
When the researchers broke down the data by gender, a clear picture emerged: men have consistently faced a higher risk of death than women. However, the speed at which the death rate is rising is different for each group. While men still have higher overall numbers, the rate of increase for women has been faster. This acceleration among women may be linked to unique physiological vulnerabilities to alcohol-related liver damage and the rapid progression of substance use disorders in females, alongside the heavy psychosocial stress often shouldered by women as primary caregivers.
Race and ethnicity also played a major role in the findings. For much of the study period, Hispanic and Latino populations faced the highest death rates, likely due to higher rates of untreated viral hepatitis and barriers to healthcare access. However, the landscape shifted over time. By the end of the study period, non-Hispanic White individuals had the highest death rates of any group, showing the steepest long-term increase. This rise among White populations coincides with the national opioid crisis and the growing burden of obesity-related liver disease. Meanwhile, non-Hispanic Black populations saw a sharp decline in death rates between 2003 and 2008, followed by a gradual rise, while other groups remained at lower overall levels.
Where a person lives appears to be just as critical as who they are. The study found that people living in non-metropolitan, or rural, areas now face a significantly higher risk of death compared to those in cities. In the early 2000s, urban areas had higher rates, but the trend flipped around 2002. Today, rural communities are bearing a heavier burden. This disparity is likely driven by a lack of access to specialized care; rural areas have far fewer liver specialists and mental health providers, making it difficult for patients to get timely treatment for either condition. The Midwest, in particular, has seen some of the highest rates, reflecting the region's intense struggle with opioid use and the spread of hepatitis C through injection drug use.
Age was another defining factor. The highest death rates were consistently found in adults between the ages of 55 and 74. This age group represents a "perfect storm" where decades of liver damage from alcohol or viruses have accumulated, and the onset of age-related mental health issues or the stress of retirement can worsen the situation. Younger adults and those over 85 had lower rates, though the risk for the youngest group studied (35 to 44) has been rising sharply in recent years.
Looking ahead, the researchers used statistical models to project these trends into the future. Their simulations suggest that if nothing changes, the death rate will continue to climb, reaching an estimated 4.71 per 100,000 by 2030. This forecast indicates that the current trajectory is unsustainable and that the gap between different demographic groups is likely to widen further. The study concludes that addressing this crisis requires more than just treating individual patients; it demands systemic reforms to fix the structural inequities in healthcare access, particularly for men, rural residents, and specific racial groups who are currently paying the highest price. Without significant changes in how care is delivered and how public health policies address these intertwined conditions, the rising tide of mortality is expected to continue.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.